On Tuesday, Capricor Therapeutics Inc (NASDAQ: CAPR) opened higher 6.85% from the last session, before settling in for the closing price of $18.09. Price fluctuations for CAPR have ranged from $2.68 to $21.98 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 339.72% over the past five years. Company’s average yearly earnings per share was noted -47.71% at the time writing. With a float of $27.08 million, this company’s outstanding shares have now reached $31.15 million.
Let’s look at the performance matrix of the company that is accounted for 102 employees. In terms of profitability, gross margin is 95.31%, operating margin of -109.7%, and the pretax margin is -102.93%.
Capricor Therapeutics Inc (CAPR) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Capricor Therapeutics Inc is 16.78%, while institutional ownership is 19.92%. The most recent insider transaction that took place on Sep 20 ’24, was worth 14,999,998. In this transaction 10% Owner of this company bought 2,798,507 shares at a rate of $5.36, taking the stock ownership to the 7,090,351 shares. Before that another transaction happened on Oct 12 ’23, when Company’s Director bought 410 for $2.75, making the entire transaction worth $1,128. This insider now owns 31,536 shares in total.
Capricor Therapeutics Inc (CAPR) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -47.71% per share during the next fiscal year.
Capricor Therapeutics Inc (NASDAQ: CAPR) Trading Performance Indicators
Check out the current performance indicators for Capricor Therapeutics Inc (CAPR). In the past quarter, the stock posted a quick ratio of 1.37. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 23.17.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.93, a number that is poised to hit -0.36 in the next quarter and is forecasted to reach -0.71 in one year’s time.
Technical Analysis of Capricor Therapeutics Inc (CAPR)
Capricor Therapeutics Inc (NASDAQ: CAPR) saw its 5-day average volume 5.56 million, a positive change from its year-to-date volume of 1.04 million. As of the previous 9 days, the stock’s Stochastic %D was 82.38%. Additionally, its Average True Range was 2.10.
During the past 100 days, Capricor Therapeutics Inc’s (CAPR) raw stochastic average was set at 85.64%, which indicates a significant increase from 84.47% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 255.09% in the past 14 days, which was higher than the 126.18% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.62, while its 200-day Moving Average is $5.50. Nevertheless, the first resistance level for the watch stands at $21.12 in the near term. At $22.90, the stock is likely to face the second major resistance level. The third major resistance level sits at $24.34. If the price goes on to break the first support level at $17.90, it is likely to go to the next support level at $16.46. The third support level lies at $14.68 if the price breaches the second support level.
Capricor Therapeutics Inc (NASDAQ: CAPR) Key Stats
There are currently 31,979K shares outstanding in the company with a market cap of 629.00 million. Presently, the company’s annual sales total 25,180 K according to its annual income of -22,290 K. Last quarter, the company’s sales amounted to 3,970 K and its income totaled -11,000 K.
